GRANULES INDIA
Back to Income Statement
|
GRANULES INDIA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,482 Cr | ₹4,506 Cr | ₹4,512 Cr | ₹3,765 Cr | ₹32,375 Cr |
What is the latest Revenue of GRANULES INDIA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹4,482 Cr |
| Mar2025 | ₹4,506 Cr |
| Mar2024 | ₹4,512 Cr |
| Mar2023 | ₹3,765 Cr |
| Mar2022 | ₹32,375 Cr |
How is Revenue of GRANULES INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,482 Cr | -0.55 | |
| Mar2025 | ₹4,506 Cr | -0.12 | |
| Mar2024 | ₹4,512 Cr | 19.84 | |
| Mar2023 | ₹3,765 Cr | -88.37 | |
| Mar2022 | ₹32,375 Cr | - | |
Compare Revenue of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹22,902.9 Cr | 2.4% | -3.2% | 49.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 2.4% |
-3.2% |
49.1% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses